Alto Pharmacy’s Post

With health systems facing resource constraints, workforce mergers, and labor challenges, drug diversion continues to be an alarming risk to healthcare organizations, their workforce, and patients. Join Adam Beeler, Director of Pharmacy Services at Protenus, as he dives into the benefits of using an AI-driven approach to investigate drug diversion in Episode #1 of our Drug Diversion FAQ video series. 💊🏥 Sign up for the series here: https://bit.ly/3vGWzH9 #HealthcareIT #DrugDiversion #HealthcareAI #DiversionPrevention

In recent months we’ve seen big players in prescription DTx going bankrupt and laying off staff. What does this say for the future of the industry? We’ll find out at this roundtable with David Benshoof Klein and members of the HealthXL community where we’ll assess how patient and HCP adoption can be scaled effectively and who should own the charge. We’ll also look at: 💬 Revised business models as a PDT - what does go to market look like in 2024? 💬 What are some important lessons learned and what should be avoided in future? Apply to attend ➡️ https://lnkd.in/eGDuvXzY #PDT #digitalhealth #DTx

Discover the power of #HubServices in enhancing patient engagement and health outcomes. Our latest whitepaper dives deep into how these services simplify the journey for patients accessing specialty drugs, making a real-world difference. It's time to rethink patient support ➡️ https://hubs.li/Q02pQJVq0 #HealthTech #SpecialtyPharma #PatientEngagement

Exciting news! Sumitomo Corporation of Americas (SCOA) marks its entry into the U.S. healthcare market with an investment in Quest Health Solutions. This partnership represents a significant milestone for both companies to improve patient outcomes. SCOA's focus on leveraging data and AI complements our industry knowledge and approach to delivering comprehensive diabetes management solutions, including continuous glucose monitors (CGMs) and remote patient monitoring (RPM). Together, we plan to enhance the quality of life for chronic-care patients. We look forward to many growth opportunities with this ideal partnership. Seiji (CJ) Tanaka Amy Babcock Smith Jeremy Yap Adam Nadler Adam Handfinger Philip Vasta #Healthcare #DiabetesManagement #PatientCare #StrategicInvestment #GrowthPartner

Our managing director, Joseph M. Shields, Esq., was featured in this article from Inside Health Policy about the new move for #PBM transparency from Optum. Oversight is needed across the industry, but how can these large companies regulate themselves in terms of profit? It is a good first step as far as statement purposes go, but it hides what is really going on in the company. Patients and companies should do business in healthcare with someone who is transparent and has progressive policies all around. What you can't find with the Big Three, look into it with our coalition members. https://lnkd.in/emH-dwub

Germans, historically, have had strong, long-standing relationships with their general practitioners, or Hausarzt. But recent events have disrupted these relationships. ZS’s William (Bill) Coyle, Eva Struckmeyer and Kevin Santo, who serve clients in the EU, explain how partnerships with pharma can help providers make their patients feel more cared for. https://bit.ly/3JkJNRY #futureofhealth #patientcentricity

The #EmbolicProtectionDevices market is poised to reach a substantial valuation of USD 3.1 billion by the year 2032. Read More: https://lnkd.in/ef58xb5q Some of the major players are Transverse Medical Inc., Abbott, Cardinal Health, Edwards Lifesciences Corporation, among others. #HealthcareTechnology #VascularHealth #PatientSafety #MarketProjection #MedicalDevices

In a recent article for Pharmacy Times, Beena Wood predicts that 2024 will be the year of increased focus on #patientcentricity from #lifesciences organizations challenging the status quo. This will be driven by patient empowerment, accelerated personalized therapies, and regulatory mandates. Read more here: https://lnkd.in/eNdypFVM

No matter where you turn these days the topic of AI is front and center. There are many creative ways to use AI/ML/LLM across different industries. ArisGlobal is defining several innovative approaches using intelligent automation to help our life science partners. One area of focus for us is patient advocacy. Please take a moment to read this article written by our Chief Safety Product Officer (Beena Wood) to learn a bit more on a particular use case. You can also learn more by reviewing our latest automated enhancement solution LifeSphere NavaX. https://lnkd.in/gxBgittm #patientadvocacy #patientsafety #aiadoption

Kistein Monkhouse, MPA of Patient Orator , and IVI's CEO, Jason Spangler discuss the importance of meaningful patient engagement during the Drug Price Negotiation Program as part of the #InflationReductionAct in a guest column for The Evidence Base®. #value #healthequity #patientengagement #drugpricing #ira #value